Dow Down 0.03% Nasdaq Up 0.30%

Biogen Idec Inc. (BIIB)

-NasdaqGS
301.89 Down 3.51(1.15%) 10:37AM EST - Nasdaq Real Time Price
Prev Close:305.40
Open:305.00
Bid:302.88 x 100
Ask:303.00 x 200
1y Target Est:376.38
Beta:0.97
Earnings Date:Jan 27 - Feb 2 (Est.)
Day's Range:301.42 - 305.83
52wk Range:270.27 - 358.89
Volume:291,018
Avg Vol (3m):1,368,050
Market Cap:71.29B
P/E (ttm):28.59
EPS (ttm):10.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 1.15%71.29B
PFEUp 1.02%193.93B

Key Statistics

Forward P/E (1 yr):18.58
P/S (ttm):7.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :13.51
Quarterly EPS Est (Dec-14) :3.77
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.06

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of multiple sclerosis (MS), neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback